Elia S Harmatz1, Lauren Stone1, Seh Hong Lim2, Graham Lee1, Anna McGrath1, Barbara Gisabella1, Xiaoyu Peng1, Eliza Kosoy1, Junmei Yao1, Elizabeth Liu1, Nuno J Machado3, Veronica S Weiner1, Warren Slocum1, Rodrigo A Cunha4, Ki A Goosens5. 1. McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge. 2. McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge; Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts. 3. McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge; Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal. 4. Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal. 5. McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge. Electronic address: kgoosens@mit.edu.
Abstract
BACKGROUND: There are many contradictory findings about the role of the hormone ghrelin in aversive processing, with studies suggesting that ghrelin signaling can both inhibit and enhance aversion. Here, we characterize and reconcile the paradoxical role of ghrelin in the acquisition of fearful memories. METHODS: We used enzyme-linked immunosorbent assay to measure endogenous acyl-ghrelin and corticosterone at time points surrounding auditory fear learning. We used pharmacological (systemic and intra-amygdala) manipulations of ghrelin signaling and examined several aversive and appetitive behaviors. We also used biotin-labeled ghrelin to visualize ghrelin binding sites in coronal brain sections of amygdala. All work was performed in rats. RESULTS: In unstressed rodents, endogenous peripheral acyl-ghrelin robustly inhibits fear memory consolidation through actions in the amygdala and accounts for virtually all interindividual variability in long-term fear memory strength. Higher levels of endogenous ghrelin after fear learning were associated with weaker long-term fear memories, and pharmacological agonism of the ghrelin receptor during the memory consolidation period reduced fear memory strength. These fear-inhibitory effects cannot be explained by changes in appetitive behavior. In contrast, we show that chronic stress, which increases both circulating endogenous acyl-ghrelin and fear memory formation, promotes profound loss of ghrelin binding sites in the amygdala and behavioral insensitivity to ghrelin receptor agonism. CONCLUSIONS: These studies provide a new link between stress, a novel type of metabolic resistance, and vulnerability to excessive fear memory formation and reveal that ghrelin can regulate negative emotionality in unstressed animals without altering appetite.
BACKGROUND: There are many contradictory findings about the role of the hormone ghrelin in aversive processing, with studies suggesting that ghrelin signaling can both inhibit and enhance aversion. Here, we characterize and reconcile the paradoxical role of ghrelin in the acquisition of fearful memories. METHODS: We used enzyme-linked immunosorbent assay to measure endogenous acyl-ghrelin and corticosterone at time points surrounding auditory fear learning. We used pharmacological (systemic and intra-amygdala) manipulations of ghrelin signaling and examined several aversive and appetitive behaviors. We also used biotin-labeled ghrelin to visualize ghrelin binding sites in coronal brain sections of amygdala. All work was performed in rats. RESULTS: In unstressed rodents, endogenous peripheral acyl-ghrelin robustly inhibits fear memory consolidation through actions in the amygdala and accounts for virtually all interindividual variability in long-term fear memory strength. Higher levels of endogenous ghrelin after fear learning were associated with weaker long-term fear memories, and pharmacological agonism of the ghrelin receptor during the memory consolidation period reduced fear memory strength. These fear-inhibitory effects cannot be explained by changes in appetitive behavior. In contrast, we show that chronic stress, which increases both circulating endogenous acyl-ghrelin and fear memory formation, promotes profound loss of ghrelin binding sites in the amygdala and behavioral insensitivity to ghrelin receptor agonism. CONCLUSIONS: These studies provide a new link between stress, a novel type of metabolic resistance, and vulnerability to excessive fear memory formation and reveal that ghrelin can regulate negative emotionality in unstressed animals without altering appetite.
Authors: Marisa S Ghersi; L A Gabach; F Buteler; A A Vilcaes; H B Schiöth; M F Perez; S R de Barioglio Journal: Psychopharmacology (Berl) Date: 2014-12-04 Impact factor: 4.530
Authors: E Codner; F Cassorla; A N Tiulpakov; M V Mericq; A Avila; O H Pescovitz; J Svensson; K Cerchio; D Krupa; B J Gertz; G Murphy Journal: Clin Pharmacol Ther Date: 2001-07 Impact factor: 6.875
Authors: Michael Lutter; Ichiro Sakata; Sherri Osborne-Lawrence; Sherry A Rovinsky; Jason G Anderson; Saendy Jung; Shari Birnbaum; Masashi Yanagisawa; Joel K Elmquist; Eric J Nestler; Jeffrey M Zigman Journal: Nat Neurosci Date: 2008-06-15 Impact factor: 24.884
Authors: Carla M Patist; Nicolas J C Stapelberg; Eugene F Du Toit; John P Headrick Journal: Cogn Affect Behav Neurosci Date: 2018-12 Impact factor: 3.282
Authors: Jacob E Moose; Katelyn A Leets; Nilamber A Mate; John D Chisholm; James L Hougland Journal: Expert Opin Ther Pat Date: 2020-06-21 Impact factor: 6.674
Authors: Muhammad I Ul Akbar Yousufzai; Elia S Harmatz; Mohsin Shah; Muhammad O Malik; Ki A Goosens Journal: Transl Psychiatry Date: 2018-04-11 Impact factor: 6.222